The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found. People who received weekly injections of semaglutide —…
Read on
Find it hard to take time to exercise during your busy workweek? No problem, a new study says — one or two “weekend warrior” workouts…
Read on
The health problems of preemie babies cause untold heartache for new parents. But these families also face a strained financial future, a new study finds.…
Read on
Smoking marijuana during pregnancy may quell your morning sickness, but it could also harm your child’s development, a new study warns. Cannabis exposure in the…
Read on
The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows. Patients taking semaglutide — the active agent in Ozempic…
Read on
As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report…
Read on
A heart-pounding workout suppresses a person’s hunger levels better than less strenuous exercises like a brisk walk or active yoga, a new study shows. Running,…
Read on
Next time you’re on a cruise, be wary of your (or your neighbor’s) private balcony hot tub, researchers warn. These luxe cabin features were pinpointed…
Read on
Anxiety is driving more children with potentially dangerous food allergies to seek out psychological care, a new study finds. Focusing on one Ohio hospital, the…
Read on
In a move that further toughens safety standards for lead paint dust, the Environmental Protection Agency on Thursday announced the finalization of a rule that…
Read on
Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says. People with type 2…
Read on
Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and Zepbound could prevent more than 42,000 deaths a year in the United States, a…
Read on